Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	93.73	71.19	63.23	33.69	51.67	50.88
Short-Term Investments	148.07	284.54	431.01	297.5	148.93	226.01
Cash & Short-Term Investments	241.8	355.72	494.25	331.19	200.6	276.89
Cash Growth	-40.23%	-28.03%	49.23%	65.10%	-27.56%	169.42%
Accounts Receivable	-	-	-	1.98	2	9.28
Other Receivables	0.91	2.3	3	1.16	0.47	0.47
Receivables	0.91	2.3	3	3.14	2.47	9.75
Prepaid Expenses	1.76	2.98	4.53	4.85	5.4	3.36
Other Current Assets	1.13	1.26	3.73	1.13	0.98	0.76
Total Current Assets	245.59	362.26	505.5	340.31	209.44	290.75
Property, Plant & Equipment	29.14	32.77	4.78	9.91	10.94	4.32
Other Long-Term Assets	1.87	1.92	1.87	0.39	0.84	0.45
Total Assets	276.6	396.95	512.15	350.61	221.22	295.53
Accounts Payable	0.49	5.96	4.53	1.58	2.97	2.02
Accrued Expenses	15.95	26.72	22.68	19.88	11.99	9.49
Current Portion of Leases	1.19	0.54	1.32	2.46	1.87	-
Other Current Liabilities	-	-	-	-	-	0.09
Total Current Liabilities	17.62	33.22	28.52	23.91	16.83	11.6
Long-Term Debt	30.44	30.21	10.05	9.93	-	-
Long-Term Leases	28.23	29.44	-	3.43	5.33	-
Other Long-Term Liabilities	-	-	-	-	-	0.87
Total Liabilities	76.29	92.87	38.58	37.27	22.16	12.47
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,036	1,014	972.97	653.71	414.35	400.92
Retained Earnings	-835.82	-710.05	-499.75	-338.41	-215.09	-117.83
Comprehensive Income & Other	0.03	0.32	0.35	-1.96	-0.2	-0.03
Total Common Equity	200.31	304.08	473.58	313.34	199.06	283.06
Shareholders' Equity	200.31	304.08	473.58	313.34	199.06	283.06
Total Liabilities & Equity	276.6	396.95	512.15	350.61	221.22	295.53
Total Debt	59.86	60.19	11.37	15.82	7.19	-
Net Cash (Debt)	181.94	295.53	482.87	315.37	193.4	276.89
Net Cash Growth	-47.16%	-38.80%	53.11%	63.07%	-30.15%	169.42%
Net Cash Per Share	2.97	4.88	8.22	7.51	5.40	12.97
Filing Date Shares Outstanding	61.45	61.24	60.24	58.94	36.11	35.74
Total Common Shares Outstanding	61.45	60.86	59.92	48.94	36.08	35.55
Working Capital	227.96	329.05	476.98	316.4	192.61	279.16
Book Value Per Share	3.26	5.00	7.90	6.40	5.52	7.96
Tangible Book Value	200.31	304.08	473.58	313.34	199.06	283.06
Tangible Book Value Per Share	3.26	5.00	7.90	6.40	5.52	7.96
Machinery	14.07	13.87	10.53	9.61	7.97	6.56
Construction In Progress	0.15	0.35	0.05	0.07	0.04	0.3
Leasehold Improvements	2.16	2.12	1.66	1.65	1.62	0.95

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q